More rapid.
More automated.

More complete myeloid genomic profiling
with NGS.

button_request-demo

 

Myeloid Testing should
be fast

Myeloid malignancy samples can be challenging to analyze. They are complex, heterogeneous, and have the potential to proliferate rapidly. To get meaningful genetic insights, you need a rapid and streamlined approach for studying all key mutations.

 

On-Demand Webinars

 

Rapid NGS for genomic profiling of
myeloid malignancies


In this workshop, see how rapid NGS is helping to facilitate swift patient enrollment into a clinical trial aiming to investigate the effectiveness of various therapeutic agents based on genetic testing results.

Also, learn how NGS technology is advancing measurable residual disease (MRD) analysis by detecting low‑frequency variants with high sensitivity across a broad number of genes simultaneously.

 

button_watch-on-demand-webinar

 

 

yeung

Cecilia Yeung, MD
Associate Professor,
Fred Hutchinson Cancer Center
Medical Director,
Fred Hutch CLIA laboratories

 

The Impact of Fast NGS Molecular Profiling in Myeloid Malignancy Research


At EHA 2022, Dr. Dolors Colomer discussed the impact that the Oncomine Myeloid Assay GX had on turnaround times and laboratory efficiency. She presented compelling data on FLT3-ITD, showing 100% concordance between NGS and fragment analysis and the ability to detect low-frequency variants ranging in size from 12–180 bp.

 

button_watch-on-demand-webinar-1

 

 

colomer

Dolors Colomer, PhD
Head of Hematopathology
Hospital Clinic, IDIBAPS,
University of Barcelona, Spain

 

Oncomine Myeloid Assay GX V2

The Ion Torrent ™ Oncomine™ Myeloid Assay GX V2 on the Ion Torrent™ Genexus™ System provides a complete next-generation sequencing (NGS) solution that can deliver a comprehensive myeloid mutational report in as little as 24 hours.


Rapid Automated Comprehensive Trusted Insightful
New call-to-action New call-to-action New call-to-action New call-to-action New call-to-action
Go from specimen to report in as little as one day.

 6
 		Process samples with just 20 minutes of hands-on time required.

 7
 		Simultaneously profile 45 key genes (DNA) and 34 fusion drivers (RNA), covering >800 unique fusions.

 29
 		Reliably detect a wide range of variants, including challenging-to-sequence targets like FLT3-ITD.

 79
 		Get an annotated variant report, including links to latest relevant evidence.

 99

Profile All Key Myeloid Mutations with one test

Simultaneously interrogate 45 DNA target genes and 34 fusion driver genes (RNA). This broad fusion panel allows you to sequence over 800 unique fusion transcripts. Gene content on the panel has been curated to cover relevant targets for all the major myeloid disorders—AML, MDS, MPN, CML, CMML, and JMML.

MagGlassDNAGenes

0

Hot Spot Genes

0

Full Genes

0

Fusion Drivers

0

Expression Genes

0

Expression Controls

Complete Coverage of Key Genes

oncomine-myeloid-gx-ngs-assay-gene-list-2024

Detect multiple types of mutations
at once

Myeloid samples frequently harbor mutations in difficult-to-sequence regions of the genome.

The Oncomine Myeloid Assay GX v2 has been carefully engineered to reliably detect all relevant mutations associated with myeloid malignancies, including targets in challenging genes like CEBPA, FLT3, CALR and more.

dna-strands

  • Single nucleotide variants
  • Insertions and Deletions
  • Tandem duplications
  • Gene fusions

Scientific Posters

amp-poster-feature

 

Recent Performance Data from AMP

AMP Poster: Development of an automated genomic profiling assay for myeloid malignancies research

View our e-Poster published in the AMP 2021 Digital Experience Program to see recent data using the Oncomine Myeloid Assay GX v2.

> View Poster

American Association of Cancer Research
(AACR) Meeting

Fully automated sample-to-report NGS workflow for comprehensive genomic profiling of myeloid neoplasm research samples

Sarah Brozio, et al. - Thermo Fisher Scientific

> View Poster

aacr22-poster-myeloid-page-feature2

 

 

 

image_5dd6bf98022a6

 

 

It's NGS made easy

A highly integrated workflow lets you go from specimen to report with about 20 minutes of hands-on time required*. It’s never been easier to implement myeloid NGS testing in your lab.

button_request-demo

 

Automate your workflow from specimen to report

Start with any common myeloid specimen type, including whole blood, bone marrow, or peripheral blood leukocytes. From there, the Genexus System integrates and automates nucleic acid extraction, purification, quantification, library preparation, sequencing, analysis and reporting within a single software ecosystem. 

1-1

All Common Species

Whole Blood

Peripheral Blood Leukocytes (PBLs)

Bone Marrow

3-3

Automated Workflow

Nucleic acid extraction and quantification

Library preparation

Sequencing

Reporting & analysis

2-1

Annotated Variant Report

Biomarkers linked to relevant evidence from public data sources

Clear And Concise Reports


Ion Torrent Oncomine Reporter is a curated knowledgebase and reporting software that links biomarkers to relevant evidence and enables custom reporting. These tools help simplify the bioinformatics workflow and enable you to focus on finding the biological meaning of your data.

See Sample Report

report-example

 

Additional Resources

Book a demo or request a quote

Are you ready to speak to a representative?

button_request-contact

 

For Research Use Only. Not for use in diagnostic procedures. 

Are you a healthcare professional?

あなたは医療関係者ですか?



We've detected your location to be Japan.

Sorry, this page is not available in your area.